ACSelerate™ GMP Media

About American CryoStem

American CryoStem (CRYO) operates a hybrid service-based model, positioning itself as a key enabler in the cell therapy ecosystem rather than a traditional drug developer. Its mission is to standardize and commercialize adipose-derived stem cell technologies through two primary channels: direct-to-consumer personal cell banking and B2B offerings of cells, media, and contract services to researchers and therapeutic developers. The company's achievements include establishing its proprietary, closed-system ATCELL® processing platform and developing serum-free, xeno-free culture media critical for scalable cell manufacturing. Its strategy focuses on capitalizing on the growing demand for reliable cell sourcing and manufacturing support as the regenerative medicine industry matures.

Therapeutic Areas